Translational Study Identifies XPF and MUS81 as Predictive Biomarkers for Oxaliplatin-Based Peri-Operative Chemotherapy in Patients With Esophageal Adenocarcinoma
Scientific Reports - United Kingdom
doi 10.1038/s41598-018-24232-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 8, 2018
Authors
Publisher
Springer Science and Business Media LLC